Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386011699> ?p ?o ?g. }
- W4386011699 abstract "ABSTRACT Immune checkpoint blockade (ICB) therapy has significantly benefited patients with several types of solid tumors and some lymphomas. However, many of the treated patients do not have durable clinical response. It has been demonstrated that rescuing exhausted CD8 + T cells is required for ICB-mediated antitumor effects. We recently developed an immunostimulatory strategy based on silencing STAT3 while stimulating immune responses by CpG, ligand for Toll-like receptor 9 (TLR9). The CpG-small interfering RNA (siRNA) conjugates efficiently enter immune cells, silencing STAT3 and activating innate immunity to enhance T-cell mediated antitumor immune responses. In the present study, we demonstrate that blocking STAT3 through locally delivered CpG- Stat3 siRNA enhances the efficacies of the systemic PD-1 and CTLA4 blockade against mouse A20 B cell lymphoma. In addition, locally delivered CpG- Stat3 siRNA combined with systemic administration of PD-1 antibody significantly augmented both local and systemic antitumor effects against mouse B16 melanoma tumors, with enhanced tumor-associated T cell activation. Overall, our studies in both B cell lymphoma and melanoma mouse models demonstrate the potential of combinatory immunotherapy with CpG- Stat3 siRNA and checkpoint inhibitors as a therapeutic strategy for B cell lymphoma and melanoma." @default.
- W4386011699 created "2023-08-21" @default.
- W4386011699 creator A5008219651 @default.
- W4386011699 creator A5012334511 @default.
- W4386011699 creator A5018539904 @default.
- W4386011699 creator A5021119678 @default.
- W4386011699 creator A5033551989 @default.
- W4386011699 creator A5039374832 @default.
- W4386011699 creator A5067224717 @default.
- W4386011699 creator A5086999864 @default.
- W4386011699 date "2023-08-19" @default.
- W4386011699 modified "2023-10-18" @default.
- W4386011699 title "Local CpG-<i>Stat3</i>siRNA treatment improves antitumor effects of immune checkpoint inhibitors" @default.
- W4386011699 cites W1548640328 @default.
- W4386011699 cites W1968749362 @default.
- W4386011699 cites W1970835134 @default.
- W4386011699 cites W1982334431 @default.
- W4386011699 cites W1999468766 @default.
- W4386011699 cites W2006514214 @default.
- W4386011699 cites W2014723748 @default.
- W4386011699 cites W2024767948 @default.
- W4386011699 cites W2031268426 @default.
- W4386011699 cites W2047117683 @default.
- W4386011699 cites W2059287377 @default.
- W4386011699 cites W2066211228 @default.
- W4386011699 cites W2100860369 @default.
- W4386011699 cites W2112023046 @default.
- W4386011699 cites W2114027214 @default.
- W4386011699 cites W2128506942 @default.
- W4386011699 cites W2130208695 @default.
- W4386011699 cites W2136176800 @default.
- W4386011699 cites W2137285200 @default.
- W4386011699 cites W2141048422 @default.
- W4386011699 cites W2155164361 @default.
- W4386011699 cites W2157217116 @default.
- W4386011699 cites W2159027903 @default.
- W4386011699 cites W2168478794 @default.
- W4386011699 cites W2324177572 @default.
- W4386011699 cites W2341757884 @default.
- W4386011699 cites W2435243879 @default.
- W4386011699 cites W2546632559 @default.
- W4386011699 cites W2592666036 @default.
- W4386011699 cites W2655262992 @default.
- W4386011699 cites W2735213270 @default.
- W4386011699 cites W2783142245 @default.
- W4386011699 cites W2784296240 @default.
- W4386011699 cites W2786472249 @default.
- W4386011699 cites W2904099327 @default.
- W4386011699 cites W2979941292 @default.
- W4386011699 cites W2980505578 @default.
- W4386011699 cites W2990621788 @default.
- W4386011699 cites W2991118872 @default.
- W4386011699 cites W3005326482 @default.
- W4386011699 cites W3017198327 @default.
- W4386011699 cites W3049007463 @default.
- W4386011699 cites W3085427829 @default.
- W4386011699 cites W3098043085 @default.
- W4386011699 cites W3112770004 @default.
- W4386011699 cites W3164445007 @default.
- W4386011699 cites W3203575974 @default.
- W4386011699 cites W3216879828 @default.
- W4386011699 cites W4214816481 @default.
- W4386011699 cites W4312748751 @default.
- W4386011699 cites W4327857219 @default.
- W4386011699 cites W4378715596 @default.
- W4386011699 cites W4380991984 @default.
- W4386011699 cites W7468802 @default.
- W4386011699 doi "https://doi.org/10.1101/2023.08.17.553571" @default.
- W4386011699 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37645787" @default.
- W4386011699 hasPublicationYear "2023" @default.
- W4386011699 type Work @default.
- W4386011699 citedByCount "0" @default.
- W4386011699 crossrefType "posted-content" @default.
- W4386011699 hasAuthorship W4386011699A5008219651 @default.
- W4386011699 hasAuthorship W4386011699A5012334511 @default.
- W4386011699 hasAuthorship W4386011699A5018539904 @default.
- W4386011699 hasAuthorship W4386011699A5021119678 @default.
- W4386011699 hasAuthorship W4386011699A5033551989 @default.
- W4386011699 hasAuthorship W4386011699A5039374832 @default.
- W4386011699 hasAuthorship W4386011699A5067224717 @default.
- W4386011699 hasAuthorship W4386011699A5086999864 @default.
- W4386011699 hasBestOaLocation W43860116991 @default.
- W4386011699 hasConcept C104317684 @default.
- W4386011699 hasConcept C119056186 @default.
- W4386011699 hasConcept C126322002 @default.
- W4386011699 hasConcept C150194340 @default.
- W4386011699 hasConcept C150903083 @default.
- W4386011699 hasConcept C170493617 @default.
- W4386011699 hasConcept C190727270 @default.
- W4386011699 hasConcept C203014093 @default.
- W4386011699 hasConcept C207001950 @default.
- W4386011699 hasConcept C22615655 @default.
- W4386011699 hasConcept C25938499 @default.
- W4386011699 hasConcept C2777701055 @default.
- W4386011699 hasConcept C2778468042 @default.
- W4386011699 hasConcept C2779138994 @default.
- W4386011699 hasConcept C2780851360 @default.
- W4386011699 hasConcept C502942594 @default.
- W4386011699 hasConcept C54009773 @default.
- W4386011699 hasConcept C54355233 @default.